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Abstract
Infertility results in a country with a low birth rate and an aging population, and thus 
there is vested interest in treating this problem by using both complementary and alter‐
native therapies, in addition to conventional western medicine. Traditional Chinese med‐
icine (TCM) has been widely used for healthcare in the Eastern world for thousands of 
years. This chapter describes the evidence to support the role of TCM in the management 
of male and female infertility.
Keywords: complementary and alternative therapy, traditional Chinese medicine, 
acupuncture and moxibustion, infertility
1. Introduction
1.1. Definition
Normal fertility was previously defined as the ability to conceive within 2 years of regular 
unprotected sexual intercourse [1, 2]. Recently, infertility has been defined as failure to con‐
ceive within 1 year of regular unprotected sexual intercourse in women less than 35 years old, 
or within 6 months of unprotected sexual intercourse in women older than 35 years old [2, 3].
1.2. Epidemiology
According to a World Health Organization (WHO) report, the prevalence of infertility has 
increased since 1990, and the most recent data from 2010 estimated the worldwide incidence 
of infertile couples to be approximately 48.5 million (Figure 1) [4]. In the United States, the 
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 percentage of married women aged 15–44 years old who were infertile decreased from 8.5% in 
1982 (2.4 million women) to 6.0% (1.5 million) in 2006–2010 [5]. In Taiwan, the total female fertility 
rate decreased from 7.04 million in 1951 to 1.175 million in 2015 [6]. Taiwan has thus become one 
of the countries with the lowest fertility rates in the world. In China, the 1‐ and 2‐year infertility 
rates in newly married couples were 12.5 and 6.6%, respectively [7]. In 2004, a WHO evaluation 
of Demographic and Health Surveys (DHS) data estimated that more than 186 million ever‐mar‐
ried women of reproductive age were infertile, translating into one in every four couples [8].
1.3. Impact
A low fertility rate results in a low birth rate and an aging country. According to the Taiwan 
Population Policy White Paper, the total population of Taiwan is expected to decrease after 
2022 [9]. A review showed that infertility or subfertility is associated with intimate partner 
violence (IPV) in low‐ and middle‐income countries (LMICs) [10]. Certain fertility treatments 
may increase the risk of ovarian or breast cancer [11, 12], while others have poor pharmaco‐
logical efficacy in infertile women older than 40 years [13]. Around one‐fifth of all subfertile 
couples seeking fertility treatment have clinically significant levels of depression, anxiety, 
and suffering, but the effects of educational and psychological interventions on mental health 
outcomes and pregnancy outcomes including distress, and live birth or ongoing pregnancy 
rates, is unclear owing to the very low quality of evidence [14].
2. Etiology
Around 15% of couples have difficulty conceiving [15]. The etiology of infertility can be 
broadly classified into female‐ and male‐related factors. Among distinguishable female fac‐
Figure 1. Worldwide prevalence of primary female infertility (2010). Infertility prevalence is indexed based on the age of 
the female partner; age‐standardized prevalence among women aged 20–44 years old is shown here [4].
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tors, which are responsible for 81% of female infertility, the most common are ovulatory dis‐
orders (25%), endometriosis (15%), pelvic adhesions (12%), tubal blockage (11%), other tubal 
abnormalities (11%), and hyperprolactinemia (7%) [16]. Male factor infertility affects around 
30–55% of all couples and is the most difficult form of infertility to treat [17]. The causes of 
male infertility include environmental disruptors, genetic defects, physiological and endo‐
crine failure, and testicular pathologies [18].
According to the theory of traditional Chinese medicine, syndromes of female infertility can 
be classified as the following: kidney deficiency, stagnation of liver qi, static blood blocking in 
uterine, and accumulation of phlegm‐wetness in the body. Constitution has a great effect on 
the syndrome patterns of many diseases including infertility. A report showed that the con‐
stitution ratio of yang deficiency, phlegm damp, and yin deficiency was 29.5, 20.0, and 21.0%, 
respectively, in sterility patients [19]. This report also pointed that kidney deficiency syndrome 
was positively correlated with yin deficiency and yang deficiency constitution, blood stasis syn‐
drome was positively associated with blood stasis and yang deficiency constitution, and liver 
stagnation syndrome was positively correlated with phlegm damp and damp heat constitution.
2.1. Ovulatory disorders
A history of regular menses with molimina (breast tenderness, bloating, cramping, mood 
changes) is suggestive of ovulation in the majority (95%) of women [20]. Anovulation and 
oligo‐ovulation lead to infertility because an oocyte is not available every month for fertil‐
ization. A woman's fecundability reaches a peak in her late‐twenties and decreases with 
advancing age, with a more rapid decline after her mid‐thirties [21]. Ovarian ageing causes 
a progressive loss of the finite pool of primordial follicles and a decrease in the quality of 
oocytes, mainly because of the accumulation of chromosomal abnormalities [22]. Polycystic 
ovarian syndrome (PCOS) is a common ovulatory disorder, and patients with this diagnosis 
are often obese and oligomenorrheic. They tend to have difficulty conceiving owing to ovula‐
tory dysfunction as well as poor oocyte quality and endometrial receptivity [23]. However, 
the results of epidemiologic data obtained mainly from comparative studies and cohorts, 
have concluded that the role and size (<6 cm) of ovary cysts in infertility is controversial [24].
2.2. Endometriosis
The rate of infertility among women with endometriosis ranges from 30 to 50%, and dys‐
function is due to various mechanisms including pelvic adhesions, abnormal tubal transport, 
implantation defects, and intraperitoneal inflammation, which can decrease oocyte quality or 
oocyte‐sperm interactions [25].
2.3. Pelvic adhesions
Most adhesions occur after surgical procedures, but can also occur following infection, isch‐
emia, endometriosis, or reaction to a foreign body, and these cause infertility by distort‐
ing pelvic anatomy and by blocking the fallopian tubes [26]. Peritubal adhesions negatively 
affect ovum transportation, while periovarian adhesions inhibit ovum release and ovulatory 
function [27, 28].
Complementary and Alternative Therapy with Traditional Chinese Medicine for Infertility
http://dx.doi.org/10.5772/66971
89
2.4. Tubal blockage and other tubal abnormalities
Tubal anomalies that contribute to infertility include congenital absence and major diver‐
ticula, duplication of the tubes, tubal occlusion, and hydrosalpinx [29, 30]. Other causes of 
tubal infertility include endometriosis, intrauterine contraceptive devices, infections (gonor‐
rhea, chlamydia trachomatis, and genital tuberculosis), and postoperative complications of 
abdominal surgery [31].
2.5. Hyperprolactinemia
Symptoms of hyperprolactinemia include amenorrhea, oligomenorrhea, infertility, decreased 
sexual desire, and habitual abortion. Women may also have signs of chronic hyperandrogen‐
ism such as acne and hirsutism, which may be related to increasing dehydroepiandrosterone 
sulfate (DHEAS) secretion from the adrenal glands [32].
3. Diagnosis
History taking and physical examination are paramount to understanding the etiology of 
the infertility, and should be undertaken in both partners after 1 year of trying to conceive. 
In certain cases, investigation is indicated after 6 months of unprotected intercourse, such as 
when the female partner is over 35 years old or has a history of oligomenorrhea or amenor‐
rhea, known or suspected endometriosis or tubal disorders, a past history of chemotherapy or 
radiation therapy, and in couples in which the male partner is known to be subfertile.
3.1. History taking
A menstrual history (menstrual interval and characteristics) should be elicited in all female 
patients in order to understand their ovulatory cycles. For instance, regular monthly cycles 
with premenstrual symptoms (breast tenderness, ovulatory pain, bloating) suggest that the 
patient is ovulating, whereas severe dysmenorrhea may indicate endometriosis.
A personal and lifestyle history should also be obtained from all infertile couples, including 
details about occupations; ages; stressors; levels of exercise; diets; and consumption of alco‐
hol, tobacco, and other substances which can influence fertility [33]. It is also important to take 
a sexual history, including an evaluation of the frequency of intercourse and of underlying 
problems such as sexual dysfunction. Infrequent or inappropriately timed sexual intercourse 
can result in infertility.
Clinicians should elicit a full medical, surgical, and obstetric history including information 
about the number of previous pregnancies, type and number of deliveries, and number of 
abortions (including spontaneous and induced) [32]. A gynecological history should evaluate 
any history of pelvic inflammatory disease, sexually transmitted infections, and treatment of 
abnormal pap smears, as well as uncover any history of procedures or medications, which 
could be related to infertility. In addition, a review of systems should be conducted in order 
to evaluate whether a patient has symptoms of dyspareunia, hypo‐/hyperthyroidism, pelvic 
or abdominal pain, galactorrhea, or hirsutism [34].
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A family history of infertile couples should record in detail whether any family members 
have birth defects, mental retardation, genetic mutations, or fertility issues. The most com‐
mon inherited cause of infertility is fragile X syndrome, which presents as premature ovarian 
failure (POF) in women, and which can lead to developmental delay or learning problems 
in men [35].
3.2. Physical examination
The physical examination can uncover signs indicative of latent causes of infertility. The 
patient's body mass index (BMI) and fat distribution should be measured and calculated, as 
an abnormally low BMI is related to infertility, whereas abdominal obesity is associated with 
insulin resistance [34].
In women, the presence of vaginal and cervical discharge or anatomic abnormalities may 
indicate an underlying infection or Müllerian anomaly, respectively. If the uterus is enlarged, 
irregular, or lacks mobility, this may suggest the presence of a uterine abnormality such as 
endometriosis, leiomyoma, or pelvic adhesions. Chronic pelvic inflammatory disease or 
endometriosis presents with tenderness, or with masses in the adnexa or posterior cul‐de‐sac 
(pouch of Douglas), while endometriosis also has palpable tender nodules at the rectovaginal 
septum or uterosacral ligaments [35].
Patients with Turner syndrome have absent periods, and distinctive morphological features 
including a squarely shaped chest, and a stocky, short body habitus. Those with hypogo‐
nadotropic hypogonadism have primary amenorrhea and unremarkable secondary sexual 
characteristics. The presence of galactorrhea, thyroid gland anomalies, or signs of androgen 
excess such as acne, hirsutism, virilization, and male pattern baldness indicate an endocri‐
nopathy (e.g., polycystic ovarian syndrome, adrenal disorders, hyper‐ or hypothyroidism, 
hyperprolactinemia) [33, 35].
In men, anatomic abnormalities or discharge from the penis, scrotum, and urethral meatus 
may indicate the presence of an inguinal/femoral/scrotal hernia, cryptorchidism, or infection. 
Varicoceles, usually noted on the left side, are associated with infertility, whereas small, hard 
testes (<2 cm long) are suggestive of Klinefelter's syndrome [36].
3.3. Other diagnostic methods
Additional essential infertility evaluations include semen analyses, assessment of ovula‐
tory function by laboratory tests, and a hysterosalpingogram to uncover underlying uterine 
abnormalities and evaluate tubal patency.
Diagnostic laparoscopy is recommended for women with suspected pelvic adhesions or 
endometriosis, during which chromotubation can assess tubal patency and hysteroscopy can 
assess the uterine cavity [29, 30].
Women older than 35 years and those younger but with risk factors for POF should measure 
estradiol and follicle‐stimulating hormone (FSH) levels on day 3 in order to evaluate the ovar‐
ian reserve. Other tests such as antral follicle count, level of anti‐Müllerian hormone (AMH), 
and the clomiphene citrate challenge test (CCCT) should be performed if necessary [35].
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4. Conventional treatments and limitations
Assisted reproductive technology (ART), such as artificial insemination (AI), in vitro fertiliza‐
tion and embryo transfer (IVF‐ET), and intracytoplasmic sperm injection (ICSI), is responsible 
for up to 4% of infants born in developing countries.
ART has several iatrogenic complications including the risk of multiples, low luteal phase 
insufficiency, disabled embryo implantation, ovarian hyperstimulation syndrome (OHSS), 
and other perinatal and long‐term health conditions [37]. Furthermore, fertility treatments, 
especially IVF‐ET and ICSI, are costly and risky [38].
Intra‐uterine insemination (IUI), one form of AI, is a commonly used fertility treatment for 
couples with cervical factor infertility, unexplained subfertility, and subfertility in women 
with endometriosis after surgical resection [39]. IUI is more useful in some types of severe sex‐
ual dysfunction such a severe ejaculatory dysfunction or vaginismus; in cases of cervical factor 
or mild male factor infertility; and to prevent the transmission of sexually transmitted diseases 
such as hepatitis B/C virus (HBV/HCV) and human immunodeficiency virus (HIV) [40].
It is a relatively simple surgical procedure whereby semen that has been washed in the labo‐
ratory is inserted into the uterine cavity by using a small catheter at the time of ovulation. 
IUI allows sperm to bypass the potentially hostile cervix, and thus increases the number of 
sperm that reach the uterine cavity and oocyte [40]. The technique can be performed either 
with or without added medications to encourage ovarian hyperstimulation (OH). In the latter 
method, follicular growth is monitored either via regular ultrasound monitoring to visualize 
the follicles or by measuring the preovulatory luteinizing hormone level rise in the serum or 
urine. In the former, ovulation is induced by an injection of human chorionic gonadotropin 
(hCG). Timed intercourse (TI), a less invasive method than IUI, involves giving couples infor‐
mation about cycle monitoring so that they can time intercourse appropriately.
Nevertheless, a systematic review revealed that there is no difference in live birth or multiple 
pregnancy rates in most couples with unexplained subfertility treated with either IUI or TI, 
both with and without OH [39].
5. Traditional Chinese medicine
Traditional Chinese medicine (TCM) formulas have been used to treat female and male infer‐
tility for hundreds of years. Classically, the TCM formulas are combined with several single 
herbs to treat a specific disease. Some of the single herbs that have been used in women include 
Semen Cuscutae, Semen Lantaginis, Herba Leonuri Japonici, and Fructus Ligustri Lucidi, and 
were first recorded in the Chinese classic Shi Jing (the Book of Songs) over 2000 years ago.
5.1. Female infertility
The results of one systematic review revealed that treatment with Chinese herbal medicine 
can increase pregnancy rates 2‐fold in a 4‐month period compared to western fertility drugs 
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or IVF [41]. This report also stated that evaluating the quality of the menstrual cycle is essen‐
tial in order to effectively treat female infertility by TCM. However, in a recent well‐con‐
trolled clinical trial, there was no significant difference in fertility outcomes after laparoscopy 
between women with minimal/mild endometriosis treated with oral contraceptives (OC), 
or OC and Dan&e mixture (composed of six herbs) [42]. A study from the National Health 
Insurance Research Database (NHIRD) in Taiwan has revealed the most commonly used TCM 
formulas for the management of female infertility [43]. At the top of the list are Dang‐Gui‐Sha‐
Yao‐San and Wen‐Jing‐Tang; the former is used for abdominal pain during pregnancy, while 
the latter is used for dysmenorrhea and infertility, and acts by promoting blood circulation 
to prevent blood stasis, by warming the meridians to dissipate cold, and by tonifying qi to 
nourish the blood. The herbal formulas and single herbs commonly used for the treatment of 
female infertility are described below. The effects of these herbs on the endocrine regulation 
effects of the menstrual cycle and the ovulation rate will also be explored. Other commonly 
prescribed formulas that are used to relieve infertility‐related symptoms and diseases such as 
premenstrual syndrome (Jia‐Wei‐Xiao‐Yao‐San), irregular menstrual cycles (Zou‐Gui‐Wan, 
You‐Gui‐Wan), uterine fibroids (Gui‐Zhi‐Fu‐Ling‐Wan), diarrhea during menstruation (Shen‐
Ling‐Bai‐Zhu‐San), dysmenorrhea (Shao‐Fu‐Zhu‐Yu‐Tang), abnormal uterine bleeding (Gui‐
Pi‐Tang), amenorrhea, or oligomenorrhea (Si‐Wu‐Tang), do not fall within the scope of this 
review.
5.2. Male infertility
A recent study revealed that changes in the metabolic pathways, which regulate aromatic 
amino acids, tricarboxylic acid cycle, and sphingolipid metabolism may play an important 
role in the origin of Kidney‐Yang deficiency syndrome (KYDS)‐associated male infertility [44]. 
This research offered a new way for metabolomics analysis of seminal plasma to differentiate 
TCM syndromes of infertile males. The Chinese medicine Huzhangdanshenyin is used for 
male immune‐factor infertility and has been shown to be more effective than prednisone [45]. 
The medicine works by improving the antisperm‐antibody‐reversing ratio; and ameliorating 
sperm indexes such as sperm motility, viability, and density, without severe adverse effects. 
Another Chinese medicine, Bushen Shengjing Decoction (BSSJD), has the effect of decreasing 
semen levels of reactive oxygen species (ROS), improving the quality of sperm, and increasing 
the natural fecundity of patients with severe oligospermia and azoospermia (SOA), thus rais‐
ing the viability of their sperm in order to increase the ovarian fertilization rate and clinical 
pregnancy rate in ICSI cycles [46].
5.3. Chinese herbal formulas for infertility
5.3.1. Dang‐Gui‐Sha‐Yao‐San
Dang‐Gui‐Sha‐Yao‐San consists of Angelicae sinensis Radix, Paeoniae Radix, Poriz, 
Atractylodis ovatae Rhizoma, Alismatis Rhizoma, and Ligustici Rhizoma. According to the 
principles of TCM, Dang‐Gui‐Shao‐Yao‐San has the effect of nourishing liver blood, invig‐
orating the spleen, and eliminating wetness. A previous study which used a Grading of 
Recommendations Assessment, Development and Evaluation method (GRADE) to evaluate 
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the quality of evidence for Dang‐Gui‐Sha‐Yao‐San concluded that this formula was likely to 
be beneficial and safe for the treatment of primary dysmenorrhea [47]. Another clinical study 
showed that it may be useful for resolving the symptoms of mild or moderate hypochromic 
anemia secondary to uterine myoma‐induced menorrhagia [48].
5.3.2. Wen‐Jing‐Tang
Wen‐Jing‐Tang consists of Cinnamomi Ramulus, Evodiae Fructus, Ligustici Rhizoma, 
Angelicae sinensis Radix, Paeoniae Radix, Zingiberis Rhizoma Recens, Moutan Radicis 
Cortex, Ophiopogonis Tuber, Pinelliae Tuber, Ginseng Radix, Glycyrrhizae Radix, and Asini 
Corii Gelatinum. According to the principles of TCM, Wen‐Jing‐Tang has the effect of pro‐
moting blood circulation to dispel blood stasis, of dispelling cold by warming the meridians, 
of benefiting qi, and of nourishing the blood. Wen‐Jing‐Tang has been shown to effectively 
regulate endocrine conditions such as plasma LH and estradiol levels in PCOS patients with 
ovulatory dysfunction without taking eight‐principle pattern identification into consider‐
ation. The study concluded that Wen‐Jing‐Tang can be used to treat PCOS in women with 
various constitutions (as determined by the matching theory of eight‐principle pattern iden‐
tification) in clinical management [49]. Another report showed that combined therapy with 
Wen‐Jing‐Tang and clomiphene induced ovulation without OHSS in infertile patients who 
did not respond to clomiphene citrate alone [50].
5.3.3. Jia‐Wei‐Xiao‐Yao‐San
Jia‐Wei‐Xiao‐Yao‐San consists of Moutan Radicis Cortex, Radix Paeoniae Rubra, Bupleuri 
Radix, Angelicae Sinensis Radix, Atractylodis Ovatae Rhizoma, Poria, Glycyrrhizae Radix, 
Zingiberis Rhizoma Recens, and Menthae Herba. According to the principles of TCM, Jia‐
Wei‐Xiao‐Yao‐San disperses stagnated liver qi, suppresses heat, and nourishes the blood. 
According to the NHIRD in Taiwan, Jia‐Wei‐Xiao‐Yao‐San‐based Chinese herbal medicine 
combinations were most frequently used for PMS and primary dysmenorrhea [51]. However, 
the exact mechanism whereby Jia‐Wei‐Xiao‐Yao‐San improves fertility is unclear. In one 
study, Jia‐Wei‐Xiao‐Yao‐San had no effect on serum levels of E2 and FSH, but did improve 
climacteric symptoms, especially in patients with hormone replacement therapy resistance 
who strongly complained of psychological symptoms [52]. These findings imply that Jia‐Wei‐
Xiao‐Yao‐San may affect fertility via as‐yet undiscovered mechanisms.
5.3.4. You‐Gui‐Wan
You‐Gui‐Wan consists of Rhizoma Rehmanniae Praeparata, Rhizoma Dioscoreae, Fructus Lycii, 
Fructus Corni, Eucommia ulmoides Oliv, Semen Cuscutae, Colla Cornus Cervi, Angelicae 
sinensis Radix, Radix Aconiti Praeparata, and Cinnamomum cassia Blume. According to the 
principles of TCM, You‐Gui‐Wan acts by gently reinforcing the Kidney‐Yang, supplement‐
ing body essence, and replenishing blood. Previous research has shown that You‐Gui‐Wan 
medicated serum can significantly increase the percentage of mature oocytes, and modulate 
mRNA expression of a number of signaling molecules including protein kinase A (PKA), 
cAMP‐response element binding protein (CREB), mitogen‐activated protein kinases (MAPK), 
protein kinase C (PKC), protein kinase G (PKG), maturation promoting factor (MPF), as well 
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as concentrations of cyclic adenosine monophosphate (cAMP), cyclic guanosine monophos‐
phate (cGMP), and nitric oxide (NO) [53]. It has also been reported that patients treated with 
You‐Gui‐Wan had higher rates of successful IVF compared to those treated with FSH (with or 
without normal serum). In animal studies, You‐Gui‐Wan has been shown to increase sperm 
fertilizing ability by increasing sperm acrosin activity and promoting the acrosome reaction, 
which resulted in a higher percentage of zygotes in mice treated with You‐Gui‐Wan com‐
pared to control mice [54].
5.3.5. Zou‐Gui‐Wan
Zou‐Gui‐Wan consists of Colla Cornus Cervi, Colla Plastri Testudinis, Rhizoma Rehmanniae 
Praeparata, Rhizoma Dioscoreae, Fructus Lycii, Fructus Corni, Radix Cyathulae, and Semen 
Cuscutae. According to the principles of TCM, You‐Gui‐Wan gently reinforces the Kidney‐
Yang, supplements body essence, and replenishes the marrow. Zou‐Gui‐Wan has also been 
shown to affect gene expression within germ cells, whereas You‐Gui‐Wan has stronger effects 
on estradiol production during the differentiation of stem cells derived from human first tri‐
mester umbilical cords into oocyte‐like cells in vitro [55]. Another report showed that Zou‐
Gui‐Wan promptly and effectively restores ovarian function in patients with POF after failed 
treatment with clomiphene citrate for 8 months [56].
5.4. Single Chinese herbs for infertility
5.4.1. Herba Cistanche
Herba Cistanche, also called Rou Cong Rong in Chinese, originated from Cistanche deserticola 
Y.C. Ma. According to the principles of TCM, Herba Cistanche invigorates the kidney‐yin, and 
replenishes the vital essence and the blood. It is used as a roborant in a formula for chronic 
renal disease, impotence, female infertility, morbid leucorrhea, profuse menorrhagia, and 
senile constipation [57]. It also controls the hypothalamic‐pituitary‐adrenal (HPA) and HPG 
axes, which may induce a balanced and smooth sexual energy effect [58]. Herba Cistanche 
also has aphrodisiac effects and can increase serum levels of progesterone and testosterone, 
improve sperm count and sperm motility, and decrease the number of abnormal sperm [59].
5.4.2. Semen Cuscutae
Semen Cuscutae, also called Tu Si Zi in Chinese, originated from Cuscuta chinensis Lam. 
According to the principles of TCM, Semen Cuscutae tonifies the kidney and is also believed to 
arrest spontaneous emission and prevent abortion. It has a multitude of other uses, including 
antiaging and anti‐inflammatory, antiabortifacient, and aphrodisiac, among others [60]. One 
study has demonstrated that flavonoids obtained from semen cuscutae (FSCs) can be used 
in the treatment of ovarian endocrine dysfunction in psychologically stressed rats through 
increasing luteinizing hormone receptor (LHR) expression in the ovaries and estrogen recep‐
tor (ER) expression in the hippocampus, hypothalamus, and pituitaries, but without any 
effect on follicle‐stimulating hormone receptor (FSHR) expression in the ovaries [61]. Another 
study demonstrated that total flavones from semen cuscutae (TFSC) treatment can improve 
Kidney‐Yang deficiency symptoms by recovering the levels of testosterone and increasing 
androgen receptor (AR) mRNA and protein expression in the testicles and kidneys [62].
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5.4.3. Herba Leonuri Japonici
Herba Leonuri Japonici, commonly called Chinese motherwort, originated from Leonurus 
japonicus Houtt (Labiatae). Related variants of this species include Leonurus sibiricus auct. 
pl., Leonurus artemisia (Lour.) S.Y. Hu., Leonurus heterophyllus sweet, and Stachys artemisia 
Lour [63]. According to the principles of TCM, Herba Leonuri Japonici promotes blood flow 
to regulate menstruation and induces diuresis to alleviate edema. It is also referred to as Yi 
Mu Cao in Chinese, which translates literally into “beneficial herb for mothers,” and is used 
to manage dysmenorrhea, amenorrhea, menoxenia, lochia, edema, and other gynecological 
problems but is contraindicated in pregnancy due to the possibility of stimulating the uterus 
[63]. The aqueous extract from the aerial part of Leonurus artemisia has the potential to treat 
dysmenorrhea by increasing the serum progesterone level, inhibiting inflammation, relax‐
ing uterine spasms, and decreasing prostaglandin F2α (PGF2α) and prostaglandin E2 (PGE2) 
concentrations in uterine smooth muscle [64].
6. Acupuncture and moxibustion
As with TCM and single Chinese herbal therapy, acupuncture and moxibustion have also been 
used to treat female or male infertility for hundreds of years. Traditionally, acupuncture and 
moxibustion were performed by inserting needles or burning moxa sticks into specific points 
(acupoints) on the meridians. Acupuncture and moxibustion work by regulating energy flow, 
also called Qi in Chinese, over the meridians. Newer therapeutic methods include electro‐acu‐
puncture (EA), laser‐acupuncture, burning moxa granules on the top of the needles, points 
pasting, and far‐infrared moxibustion. Some meridians or acupoints have been indicated for 
the management of gynecological or obstetric problems, and these include Taichong (LR 3), 
Taixi (KI 3), Sanyinchiao (SP 6), and Gongsun (SP 4). These points were the earliest recorded 
in the Chinese classic Huangdi Neijing (the Classic of Inner Canon of Huangdi) around the 
time of the Han dynasty, and in the Chinese classic Zhenjiu Jiayi Jing (the A‐B Classic of 
Acupuncture and Moxibustion) during the Jin dynasty.
6.1. Male infertility
Gonadotropin‐releasing hormone (GnRH) is released by the hypothalamus and stimulates 
ovulation and sperm production in women and men, respectively. Thus, its deficiency con‐
tributes to both male and female infertility [65]. One study showed that repeated EA on the 
arcuate nucleus (Arc) can regulate the function of the HPG axis by suppressing Arc discharge, 
serum testosterone, sperm count, and GnRH mRNA expression [66]. Therefore, electrical stim‐
ulation may be an effective alternative to medications to regulate the HPG axis [67]. Another 
clinical trial in humans showed that 10‐Hz EA stimulation of the abdominal acupuncture 
points ST‐29 (guilai) increased testicular blood flow (TBF), but simple needle insertion and 2‐
Hz EA stimulation did not [68]. The combination of acupuncture and moxibustion treatment 
has also been shown to increase the percentage of normal‐form sperm in infertile patients 
with oligoastenoteratozoospermia in a prospective, controlled, and blinded study, but the 
mechanisms remain unknown [69]. Another study revealed that acupuncture can improve 
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quick sperm motility, increase the normal sperm ratio, and improve fertilization rates and 
embryo quality in cases of idiopathic male infertility with failed ICSI [70]. According to the 
results of a systemic review from China regarding the treatment of male infertility, acupunc‐
ture appears to be as effective as TCM and more effective than western medicine alone, and 
its ability to improve sperm concentration and increase the level of grade a pulse b sperm is 
increased when applied together with either TCM or western medicine [71].
6.2. Female infertility
There is evidence to suggest that acupuncture stimulation of acupoints of the conception vessel, 
spleen, kidney, and bladder meridians improves clinical symptoms in patients with diminished 
ovarian reserve (DOR), and also lowers serum FSH, LH, and estradiol [E(2)] levels through 
regulation of the hypothalamic‐pituitary‐ovarian (HPO) axis [72]. A randomized, prospective, 
controlled clinical study revealed that acupuncture during the luteal phase of IVF/ICSI cycles 
increased clinical pregnancy and ongoing pregnancy rates [73]. Acupuncture improves IVF out‐
comes through four potential mechanisms: (1) by increasing blood flow to the uterus; (2) by reg‐
ulating neuroendocrinological factors and the ovaries; (3) by modulating cytokine levels; and 
(4) by decreasing levels of anxiety, stress, and depression [74]. A successful pregnancy relies on 
the presence of adequate uterine blood flow and endometrial thickness, and these factors are 
especially important in pregnancies conceived through IVF and ET [67]. A study of infertile 
women with a high pulsatility index (PI) and downregulated with a GnRH analog to exclude 
any fluctuating endogenous hormone effects on the PI, revealed that EA reduced uterine artery 
blood flow impedance [75]. However, the literature on the efficacy of acupuncture treatment 
for endometriosis, immune and pelvic inflammatory disease‐related infertility or subfertility 
is sparse. One study on women with steroid‐induced polycystic ovaries demonstrated that EA 
modulates the neuroendocrinological state of the ovaries by inhibiting endothelin‐1 and nerve 
growth factor (NGF), and NGF mRNA expression, most likely by modulating sympathetic 
activity in the ovaries [76]. Another similar study on estradiol valerate‐induced polycystic ova‐
ries demonstrated that EA treatments change the neuroendocrinological state in the ovaries 
by suppressing corticotropin‐releasing factor, which may play an important role in reproduc‐
tive failure [77]. Finally, the results of the Fertility Problem Inventory (FPI) and Beck Anxiety 
Inventory (BAI) questionnaires revealed that women suffer greater anxiety and sexual infertil‐
ity stress than men [78]. High levels of stress affect female hormone levels and disrupt ovulation 
by affecting the HPO axis [67]. These studies all highlight a need for additional research into 
the potential benefits of acupuncture and moxibustion for the management of infertile patients.
7. Conclusions
Infertility results in a country with a low birth rate and an aging population, and thus there is 
vested interest in treating this problem by using both complementary and alternative thera‐
pies, in addition to conventional western medicine. There is increasing scientific evidence to 
support a role for TCM in the management of male and female infertility, but further studies 
are needed to elucidate the efficacy of this alternative therapy.
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